Smith Mary L.

Smith Mary L. is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 2 public disclosures. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT). The current snapshot covers public activity from Jan 6, 2026. Reported amounts are shown as $266.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.